Call for Your FREE Evaluation (877) 503-1595

Bella Vi Insane Amp’d And Bella Vi Amp’d Up Weight Loss Drug Warning

Areas of Practice

Get a FREE Evaluation

By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.

Call for your FREE consultation with a personal attorney: (877) 503-1595

FDA

Bella Vi Insane Amp’d And Bella Vi Amp’d Up Weight Loss Drug Warning

In another example of apparently unsafe weight loss compounds being marketed in the U.S, the FDA warned consumers not to purchase or use Bella Vi Insane Amp’d or Bella Vi Amp’d Up. The warning was issues after FDA laboratory analyses confirmed that the compounds contain sibutramine, which was removed from the market in 2012 for…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, arrhythmias, artery disease, congestive heart failure, sibutramine, weight loss, Bella Vi, laxative, OTC, phenolphthalein,

Be Inspired: FDA Warning Issued

On October 9 and October10, 2013, the FDA issued several warnings related to weight loss products containing sibutramine.  One such product is marketed under the name Be Inspired.  Under the FDA advisory, consumers have been instructed not to purchase or use Be Inspired.  The warning was issued after FDA laboratory analyses confirmed that Be Inspired…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, sibutramine, Be Inspired, Dietary Supplement Health and Education Act of 1994, DSHEA,

Hepatitis Drug Determined to be Safe and Effective

According to the U.S. Department of Health and Human Services, there are 17,000 new cases of hepatitis in the United States each year.  Moreover, approximately 3.2 million individuals in the U.S. are living with chronic hepatitis.  It is spread primarily by contact with infected blood, as may occur through sharing needles or razors, and it…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Gilead Sciences, Hepatitis C, sofosbuvir, U.S. Department of Health and Human Services,